StreetInsider.com News Articles

Inhibrx Biosciences (INBX) Reiterated at Buy by Stifel After Ozekibart Data Presentation

Tue, 02 Jun 2026 07:10:13 -0400

Stifel analyst Dara Azar reiterated a Buy rating and $325.00 price target on Inhibrx Biosciences (NASDAQ: INBX).

The analyst commented, "Over the weekend at ASCO26, two Ozekibart posters were presented featuring previously disclosed data in Chondrosarcoma and Colorectal Cancer (CRC) with new granularity mainly on secondary/safety endpoints and presenter commentary. Most incremental for our CRC thesis here was the newly disclosed 11.1m single-agent response durability in Chondrosarcoma, caveated by a small responder sample, that doubles the toplined 5.5m mPFS and is likely a signal of mechanism durability in future earlier-line CRC combinations. This is important because more complex combinations become easier

Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP

Fri, 15 May 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260515/26508118.html

Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: VIKING GLOBAL INVESTORS LP

Fri, 15 May 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260515/26508118.html

Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC

Fri, 15 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26504591.html

Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: PERCEPTIVE ADVISORS LLC

Fri, 15 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26504591.html

Inhibrx Biosciences (INBX) PT Raised to $325 at Stifel

Fri, 15 May 2026 08:05:43 -0400

Stifel analyst Dara Azar raised the price target on Inhibrx Biosciences (NASDAQ: INBX) to $325.00 (from $300.00) while maintaining a Buy rating.

Inhibrx, Inc. (INBX) Tops Q1 EPS by 8c

Thu, 14 May 2026 16:52:02 -0400

Inhibrx, Inc. (NASDAQ: INBX) reported Q1 EPS of ($2.15), $0.08 better than the analyst estimate of ($2.23).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

Form 8-K Inhibrx Biosciences, For: May 14

Thu, 14 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260514/26494589.html

Form 8-K Inhibrx Biosciences, For: May 14

Thu, 14 May 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260514/26494589.html

Form 10-Q Inhibrx Biosciences, For: Mar 31

Thu, 14 May 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260514/26494438.html

Form 10-Q Inhibrx Biosciences, For: Mar 31

Thu, 14 May 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260514/26494438.html

Inhibrx Reports First Quarter 2026 Financial Results